An atypical form of 60S ribosomal subunit in Diamond-Blackfan anemia linked to RPL17 variants
Authors:
- Florence FellmannFFFlorence Fellmann
- Carol SaundersCSCarol Saunders
- Marie-Françoise O’DOnohueMOMarie-Françoise O’DOnohue
- David W. ReidDRDavid W. Reid
- Kelsey A. McFaddenKMKelsey A. McFadden
- Nathalie Montel-LehryNMNathalie Montel-Lehry
- Cong YuCYCong Yu
- Mingyan FangMFMingyan Fang
- Jianguo ZhangJZJianguo Zhang
- Beryl Royer-BertrandBRBeryl Royer-Bertrand
- Pietro FarinelliPFPietro Farinelli
- Narjesse KarboulNKNarjesse Karboul
Open Access
- 1 August 2024
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 9 (17)
Abstract
Diamond-Blackfan anemia syndrome (DBA) is a ribosomopathy associated with loss-of-function variants in more than 20 ribosomal protein (RP) genes. Here, we report the genetic, functional, and biochemical dissection of 2 multigenerational pedigrees with variants in RPL17 , a large ribosomal subunit protein–encoding gene. Affected individuals had clinical features and erythroid proliferation defects consistent with DBA. Further, RPL17/uL22 depletion resulted in anemia and micrognathia in zebrafish larvae, and in vivo complementation studies indicated that RPL17 variants were pathogenic. Lymphoblastoid cell lines (LCLs) derived from patients displayed a ribosomal RNA maturation defect reflecting haploinsufficiency of RPL17 . The proteins encoded by RPL17 variants were not incorporated into ribosomes, but 10%–20% of 60S ribosomal subunits contained a short form of 5.8S rRNA (5.8S C ), a species that is marginal in normal cells. These atypical 60S subunits were actively engaged in translation. Ribosome profiling showed changes of the translational profile, but those are similar to LCLs bearing RPS19 variants. These results link an additional RP gene to DBA. They show that ribosomes can be modified substantially by RPL17 haploinsufficiency but support the paradigm that translation alterations in DBA are primarily related to insufficient ribosome production rather than to changes in ribosome structure or composition.Keywords
Funding Information
- Agence Nationale de la Recherche (ANR-DBA-Multigenes-ANR-2015-AAP générique-CE12)
- European Union’s Horizon 2020 research and innovation program under the European Joint Research Program on Rare Diseases (COFUND-EJP No 825575)
- Agence Nationale de la Recherche (ANR EJPRD/ANR-19-RAR4-0016)
- National Institutes of Health (NIH GM139480)
This publication has 85 references indexed in Scilit:
- Impaired ribosome biogenesis in Diamond-Blackfan anemiaBlood, 2006
- Human RPS19, the gene mutated in Diamond-Blackfan anemia, encodes a ribosomal protein required for the maturation of 40S ribosomal subunitsBlood, 2006
- 5′-End formation of yeast 5.8SL rRNA is an endonucleolytic eventBiochemical and Biophysical Research Communications, 2006
- Inhibition of MDM2-mediated p53 Ubiquitination and Degradation by Ribosomal Protein L5Journal of Biological Chemistry, 2004
- Ribosomal Protein L23 Activates p53 by Inhibiting MDM2 Function in Response to Ribosomal Perturbation but Not to Translation InhibitionMolecular and Cellular Biology, 2004
- Transplantation and in vivo imaging of multilineage engraftment in zebrafish bloodless mutantsNature Immunology, 2003
- Regulation of HDM2 activity by the ribosomal protein L11Cancer Cell, 2003
- The 5′ end of yeast 5.8S rRNA is generated by exonucleases from an upstream cleavage site.The EMBO Journal, 1994
- Erythroid failure in Diamond-Blackfan anemia is characterized by apoptosis.1994
- Congenital hypoplastic anemia.1976